ºñ¼Ò¼¼Æ÷ Æó¾ÏȯÀÚ¿¡¼ Docetaxel Åõ¿© Áß ¹ß»ýÇÑ ¾Æ±Þ¼º ÇǺΠȫ¹Ý·çǪ½º 1¿¹
A Case of Docetaxel Induced Subacute Cutaneous Lupus Erythematosus
°áÇÙ¹×È£Èí±âÁúȯ 2009³â 66±Ç 5È£ p.380 ~ p.384
½ÅÁ¤¾Æ(Shin Jung-Ar) - ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Çãö¿õ(Huh Cheal-Wung) - ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±ÇÁöÀº(Kwon Ji-Eun) - ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Üº´¸®Çб³½Ç
±èÇüÁß(Kim Hyung-Jung) - ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¾Èö¹Î(Ahn Chul-Min) - ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
ÀåÀ±¼ö(Chang Yoon-Soo) - ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Abstract
Drug-induced subacute cutaneous lupus erythematosus (SCLE) is associated with use of the following classes of medications: anti-hypertensives, anti-cholesterolemia, anti-psychotics, and anti-inflammatory drugs. Docetaxel is an anti-neoplastic agent, which is widely used for treatment of non-small cell lung cancer. Few cases of docetaxel-induced SCLE have been reported in the medical literature. Here, we report the case of a 58-year-old female patient who developed drug-induced SCLE after administration of docetaxel. After 4 cycles of chemotherapy with docetaxel and cisplatin, erythematous skin eruptions developed on the patient¡¯s face. Skin biopsies of the eruptions were remarkable for interfacing dermatitis with basement membrane thickening. Immunofluorescent study revealed characteristic features of SCLE, including granular deposition of IgM, C3, and apoptotic bodies along the basement membrane. The skin eruptions resolved gradually after cessation of drug and with the use of topical corticosteroids.
Å°¿öµå
Subacute cutaneous lupus erythematosus, Drug-induced lupus erythematosus, Non-small-cell lung carcinoma, Docetaxel
KMID :
0383820090660050380
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
drug-induced subacute cutaneous lupus erythematosus (SCLE) after administration of docetaxel